Cranioplasty with custom-made titanium plates--14 years experience

The optimal material for cranial defect repair remains uncertain. While titanium is frequently used, its outcomes have not been thoroughly evaluated in large-scale studies. Prior research has shown that autologous bone grafts and other materials have variable success rates. However, the specific risks and benefits of custom-made titanium plates remain unclear. This uncertainty drives the need for detailed retrospective analysis of titanium cranioplasty outcomes. No prior work had resolved the relationship between defect size and infection rates in titanium cranioplasty. Understanding these factors is essential for refining surgical protocols. The lack of consensus on infection prophylaxis in titanium cranioplasty highlights a key gap in current knowledge. This study aims to address these uncertainties through a detailed cohort analysis.

This study aimed to evaluate the outcomes of custom-made titanium cranioplasty in a large cohort of patients. The primary objective was to assess the frequency and nature of complications following this procedure. A secondary goal was to identify factors associated with increased risk of infection. The study focused on patients from two major neurosurgical centers in Western Australia. The researchers sought to determine if defect size influenced complication rates. They also examined whether prior infections or other clinical variables impacted outcomes. The motivation for this study stemmed from the lack of consensus on optimal cranioplasty materials. The findings could inform clinical guidelines for titanium cranioplasty use.

The study employed a retrospective cohort design using medical records from two neurosurgical centers in Western Australia. Researchers retrieved and analyzed data on patients who underwent titanium cranioplasty between unspecified dates. The dataset included 127 procedures performed on 113 patients, with some patients undergoing multiple surgeries. The primary outcome measure was the incidence of complications following titanium cranioplasty. Researchers categorized complications by type and severity. They also recorded hospital stay duration and other clinical indicators. Statistical analysis was used to assess associations between variables and complication rates. The study design allowed for a detailed evaluation of long-term outcomes.

Complications following titanium cranioplasty occurred in 29% of cases, with infection being the most frequent complication at 16%. The average hospital stay was extended by 7 days due to complications. Infection rates varied significantly by defect size, with larger defects showing higher complication rates. Hemicraniectomy and bifrontal craniectomy had infection rates of 39% and 28%, respectively. Small defects showed lower infection rates, with a statistically significant difference (P = .04). No significant association was found between infection risk and the use of titanium for initial cranioplasty (P = .58). Scalp lacerations at the original surgery did not increase infection risk (P = .32). These findings suggest that defect size is a critical factor in infection risk.

The study found that complications following titanium cranioplasty are common, with infection being the most significant issue. Larger cranial defects were associated with higher infection rates, suggesting a need for tailored prophylactic strategies. The lack of significant associations between infection risk and prior surgical variables indicates that other factors may be at play. The findings suggest that more aggressive infection prevention measures are necessary for titanium cranioplasty. The authors propose that defect size should be considered when planning cranioplasty procedures. The study highlights the importance of monitoring hospital stay duration as a proxy for complication severity. These conclusions are based on the observed data and do not suggest definitive causal relationships. The results may inform future clinical protocols for titanium cranioplasty.